Results 191 to 200 of about 32,727 (251)

One century of teaching, research, and innovation in chemical engineering in Mexico: The role of chemical engineering in the background and future of polymer science and industrial production in Mexico

The Canadian Journal of Chemical Engineering, EarlyView.
Timeline of key academic milestones and individuals that shaped chemical engineering at FQ‐UNAM and in Mexico. Abstract One hundred years after the beginning of the teaching of Chemical Engineering in Mexico, which started in 1925 in the former National School of Chemical Sciences, currently Faculty of Chemistry (FQ) at National Autonomous University ...
Patricia Pérez‐Salinas, Alberto Rosas‐Aburto, Eduardo Vivaldo‐Lima   +2 more
wiley   +1 more source

Ironing out Persisters? Revisiting the Iron Chelation Strategy to Target Planktonic Bacterial Persisters Harboured in Carbapenem-Resistant Escherichia coli. [PDF]

Microorganisms
Yeo JH, Begam N, Leow WT, Goh JX, Zhong Y, Cai Y, Kwa AL.   +6 more
europepmc   +1 more source

Curcumin-polydopamine nanoparticles alleviate ferroptosis by iron chelation and inhibition of oxidative stress damage. [PDF]

RSC Adv
Lei L, Yuan J, Yang Q, Tu Q, Yu H, Chu L, Tang L, Zhang C.   +7 more
europepmc   +1 more source

NDRG1 acts as an oncogene in triple-negative breast cancer and its loss sensitizes cells to mitochondrial iron chelation. [PDF]

Front Pharmacol
Jadhav SB, Vondrackova M, Potomova P, Sandoval-Acuña C, Smigova J, Klanicova K, Rosel D, Brabek J, Stursa J, Werner L, Truksa J.   +10 more
europepmc   +1 more source

Chemical genomic analysis reveals the interplay between iron chelation, zinc homeostasis, and retromer function in the bioactivity of an ethanol adduct of the feijoa fruit-derived ellagitannin vescalagin. [PDF]

G3 (Bethesda)
Mokhtari M, Amiri P, Miller D, Gresham D, Bloor SJ, Munkacsi AB.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Iron chelation therapy

European Journal of Haematology, 2023
AbstractIron overload is a pathological condition resulting from a congenital impairment of its regulation, increased intestinal iron absorption secondary to bone marrow erythroid hyperplasia, or a chronic transfusional regimen. In normal conditions, intracellular and systemic mechanisms contribute to maintaining iron balance.
Antonella Bruzzese, Enrica Antonia Martino, Francesco Mendicino, Eugenio Lucia, Virginia Olivito, Carlo Bova, Gianfranco Filippelli, Isabella Capodanno, Antonino Neri, Fortunato Morabito, Massimo Gentile, Ernesto Vigna   +11 more
openaire   +2 more sources

Iron chelation

Blood Reviews, 1990
Adequate iron chelation in thalassaemia has resulted in a striking improvement in survival, with a reduction of cardiac mortality at age 15 years from 14-3%, and a predicted survival at age 36 years of 85%. Long term desferrioxamine (DF) therapy in thalassaemic children should be started between 2-4 years of age.
C, Hershko, A, Pinson, G, Link
openaire   +3 more sources

Oral Iron Chelators

Annual Review of Medicine, 2009
Deferoxamine (DFO) was the standard of care for transfusional iron overload for >40 years, requiring subcutaneous infusion for 8–12 h/day, 5–7 days/week. Oral iron chelators are an important development, offering the potential to improve compliance and patients’ quality of life.
M.D. Cappellini, P. Pattoneri
openaire   +2 more sources

Hydroxyquinolines as Iron Chelators

Current Medicinal Chemistry, 2003
The interest in synthetic siderophore mimics includes therapeutic applications (iron chelation therapy), the design of more effective agents to deliver Fe to plants and the development of new chemical tools for studies of iron metabolism and for a better understanding of iron assimilation processes in living systems.
J-L, Pierre, P, Baret, G, Serratrice
openaire   +2 more sources